IM Cannabis Corp. (IMCC)
IM Cannabis Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Glil Yam, TA, IL. The stock last traded at $0.13, down 2.38% on the session, giving a market capitalisation of $398,486. On trailing twelve-month figures it carries a trailing P/E of -1062.50, a net margin of -0.5%. Its beta of 2.06 implies it has historically moved more than the broad market.
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
IM Cannabis Corp. is most often compared with the following Healthcare names: